Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome SubtypesEdvardas Kaminskas, Richard Pazdur, Li-Shan Hsieh et al.|Clinical Cancer Research|2005Cited by 424
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic LeukemiaR. Angelo de Claro, Richard Pazdur, Karen M. McGinn et al.|Clinical Cancer Research|2015Cited by 165